2 patents
Utility
Methods and Compositions for Restricting Biodistribution of Aav
18 Jan 24
The present disclosure relates to an improved method of treating a patient with a recombinant adeno-associated virus (rAAV) by adjunctively administering to the patient via systemic administration a composition comprising at least one antibody or antigen-binding fragments thereof that is capable of neutralizing the non-systemically administered rAAV.
Roberto CALCEDO DEL HOYO, Luc H. VANDENBERGHE
Filed: 9 Nov 21
Utility
Recombinant Aav for Treatment of Neural Disease
2 Feb 23
The disclosure pertains to a recombinant adeno-associated virus (rAAV) comprising an Anc80L65 capsid for delivering a polynucleotide (e.g., a transgene) into the central nervous system (CNS).
Laura K. RICHMAN, Roberto CALCEDO DEL HOYO, Douglas N. SANDERS, Lisa M. STANEK, Samantha SMITH, Richard LU, Christopher TIPPER, Robert Steven Johnson
Filed: 11 Apr 22
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first